Nanjing Hanxin Pharmaceutical Technology Co., Ltd

About Nanjing Hanxin Pharmaceutical Technology Co., Ltd

About Us Founded on July 6, 2021, through the restructuring of Amphastar Pharmaceuticals, Inc. (USA) China R&D Center, Nanjing Hanxin Pharmaceuticals Co., Ltd. has a registered capital of CNY 183 million. Leveraging advanced technology platforms and strong R&D capabilities, Hanxin has emerged as a global pharmaceutical Company- engaged in the research, manufacture, and sales of peptides, proteins, and polysaccharides (APIs and finished dosage forms).

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
CMO/CDMO
Machinery and Equipment Supplier/Manufacturer
Contact info
  • Building C5 , No.9 Weidi Road,, Xianlin University Town, Xianlin Street,Qixia, Nanjing, Jiangsu, China
Meet us at

CPHI Americas 2026

Pennsylvania Convention Center, Philadelphia
2 Jun 2026 - 4 June 2026

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026